BioCentury | Oct 21, 2013
Company News

PolyTherics, Tube Pharmaceuticals deal

...but declined to disclose financial terms (see BioCentury, Aug. 5). PolyTherics Ltd. , London, U.K. Tube Pharmaceuticals GmbH...
BioCentury | Sep 23, 2013
Emerging Company Profile

Tube: Potent payloads

...The potency of Tube Pharmaceuticals GmbH 's tubulysin toxin as a conjugate payload could allow the company to...
...GmbH , Halle, Germany Synthon B.V. , Nijmegen, the Netherlands Tube Pharmaceuticals GmbH , Vienna, Austria Sidebars Tube Pharmaceuticals GmbH...
BioCentury | Jul 25, 2011
Company News

Tube Pharmaceutical GmbH, Helmholtz Centre for Infection Research cancer news

...Ascenion GmbH, the technology transfer partner of Helmholtz, and investor Austria Wirtschaftsservice formed Tube Pharmaceuticals, a preclinical...
BioCentury | Jul 25, 2011
Financial News

Tube Pharmaceuticals completes venture financing

Tube Pharmaceuticals GmbH , Vienna, Austria Business: Cancer Date completed: 7/19/11 Type: Venture financing Raised: €1 million ($1.4 million) Investor: Austria Wirtschaftsservice WIR Staff cancer...
Items per page:
1 - 4 of 4
BioCentury | Oct 21, 2013
Company News

PolyTherics, Tube Pharmaceuticals deal

...but declined to disclose financial terms (see BioCentury, Aug. 5). PolyTherics Ltd. , London, U.K. Tube Pharmaceuticals GmbH...
BioCentury | Sep 23, 2013
Emerging Company Profile

Tube: Potent payloads

...The potency of Tube Pharmaceuticals GmbH 's tubulysin toxin as a conjugate payload could allow the company to...
...GmbH , Halle, Germany Synthon B.V. , Nijmegen, the Netherlands Tube Pharmaceuticals GmbH , Vienna, Austria Sidebars Tube Pharmaceuticals GmbH...
BioCentury | Jul 25, 2011
Company News

Tube Pharmaceutical GmbH, Helmholtz Centre for Infection Research cancer news

...Ascenion GmbH, the technology transfer partner of Helmholtz, and investor Austria Wirtschaftsservice formed Tube Pharmaceuticals, a preclinical...
BioCentury | Jul 25, 2011
Financial News

Tube Pharmaceuticals completes venture financing

Tube Pharmaceuticals GmbH , Vienna, Austria Business: Cancer Date completed: 7/19/11 Type: Venture financing Raised: €1 million ($1.4 million) Investor: Austria Wirtschaftsservice WIR Staff cancer...
Items per page:
1 - 4 of 4